Publication | Closed Access

Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

Metabolic SyndromeHepatologyLiver PhysiologyDiabetesPharmacologyType 2PathologyOral Antidiabetic DrugsLiver DiseaseDiabetes MellitusFatty Liver DiseaseMedicineAtherosclerosisDyslipidemiaInflammatory BiomarkersHealth Sciences